ID   KOLF2.1J KIF5A N256S REV/WT
AC   CVCL_E4WE
SY   JIPSC001330
WW   Provider; JAX; JIPSC001330; https://www.jax.org/jax-mice-and-services/ipsc/cells-collection/JIPSC001330
CC   From: The Jackson Laboratory; Bar Harbor; USA.
CC   Population: Caucasian; British.
CC   Characteristics: Control cell line which is a CRISPR/Cas9 engineered revertant of the heterozygously edited KIF5A p.Asn256Ser (c.767A>G) cell line (JAX=JIPSC001330).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192058; Spastic paraplegia 10
DI   ORDO; Orphanet_100991; Autosomal dominant spastic paraplegia type 10
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E4WG ! KOLF2.1J KIF5A N256S SNV/WT
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//